Archival 0 8 0 8 B-cancer
tumor 9 14 9 14 I-cancer
samples 15 22 15 22 O
are 23 26 23 26 O
requested 27 36 27 36 O
, 36 37 36 37 O
but 38 41 38 41 O
are 42 45 42 45 O
not 46 49 46 49 O
required 50 58 50 58 O
for 59 62 59 62 O
eligibility 63 74 63 74 O

Eastern 0 7 75 82 B-clinical_variable
Cooperative 8 19 83 94 I-clinical_variable
Oncology 20 28 95 103 I-clinical_variable
Group 29 34 104 109 I-clinical_variable
( 35 36 110 111 I-clinical_variable
ECOG 36 40 111 115 I-clinical_variable
) 40 41 115 116 I-clinical_variable
performance 42 53 117 128 I-clinical_variable
status 54 60 129 135 I-clinical_variable
â‰¤ 61 62 136 137 O
1 63 64 138 139 B-upper_bound

Ongoing 0 7 140 147 O
bowel 8 13 148 153 B-chronic_disease
perforation 14 25 154 165 I-chronic_disease
or 26 28 166 168 O
presence 29 37 169 177 O
of 38 40 178 180 O
bowel 41 46 181 186 O
fistula 47 54 187 194 B-chronic_disease
or 55 57 195 197 O
abscess 58 65 198 205 O
or 66 68 206 208 O
history 69 76 209 216 O
of 77 79 217 219 O
small 80 85 220 225 B-chronic_disease
or 86 88 226 228 I-chronic_disease
large 89 94 229 234 I-chronic_disease
bowel 95 100 235 240 I-chronic_disease
obstruction 101 112 241 252 I-chronic_disease
within 113 119 253 259 O
3 120 121 260 261 B-upper_bound
months 122 128 262 268 I-upper_bound
of 129 131 269 271 O
registration 132 144 272 284 O
, 144 145 284 285 O
including 146 155 286 295 O
subjects 156 164 296 304 O
with 165 169 305 309 O
palliative 170 180 310 320 B-treatment
gastric 181 188 321 328 I-treatment
drainage 189 197 329 337 I-treatment
catheters 198 207 338 347 I-treatment

Previously 0 10 348 358 O
treated 11 18 359 366 O
for 19 22 367 370 O
advanced 23 31 371 379 O
cancer 32 38 380 386 B-cancer
with 39 43 387 391 O
no 44 46 392 394 O
additional 47 57 395 405 O
therapy 58 65 406 413 O
options 66 73 414 421 O
available 74 83 422 431 O
known 84 89 432 437 O
to 90 92 438 440 O
prolong 93 100 441 448 O
survival 101 109 449 457 O

Subject 0 7 458 465 O
has 8 11 466 469 O
other 12 17 470 475 O
active 18 24 476 482 B-cancer
malignancy 25 35 483 493 I-cancer

Subjects 0 8 494 502 O
with 9 13 503 507 O
asymptomatic 14 26 508 520 B-cancer
brain 27 32 521 526 I-cancer
metastases 33 43 527 537 I-cancer
or 44 46 538 540 O
spinal 47 53 541 547 B-chronic_disease
cord 54 58 548 552 I-chronic_disease
compression 59 70 553 564 I-chronic_disease
who 71 74 565 568 O
have 75 79 569 573 O
been 80 84 574 578 O
treated 85 92 579 586 O
, 92 93 586 587 O
are 94 97 588 591 O
considered 98 108 592 602 O
stable 109 115 603 609 O
, 115 116 609 610 O
and 117 120 611 614 O
who 121 124 615 618 O
have 125 129 619 623 O
not 130 133 624 627 O
received 134 142 628 636 O
corticosteroids 143 158 637 652 B-treatment
or 159 161 653 655 O
anticonvulsants 162 177 656 671 B-treatment
for 178 181 672 675 O
at 182 184 676 678 O
least 185 190 679 684 O
28 191 193 685 687 B-lower_bound
days 194 198 688 692 I-lower_bound
prior 199 204 693 698 I-lower_bound
to 205 207 699 701 O
screening 208 217 702 711 O
may 218 221 712 715 O
be 222 224 716 718 O
included 225 233 719 727 O

Subjects 0 8 728 736 O
with 9 13 737 741 O
clinically 14 24 742 752 O
significant 25 36 753 764 O
cardiovascular 37 51 765 779 B-chronic_disease
disease 52 59 780 787 I-chronic_disease
, 59 60 787 788 O
history 61 68 789 796 O
of 69 71 797 799 O
organ 72 77 800 805 B-treatment
transplant 78 88 806 816 I-treatment
or 89 91 817 819 O
allogeneic 92 102 820 830 B-treatment
bone 103 107 831 835 I-treatment
marrow 108 114 836 842 I-treatment
transplant 115 125 843 853 I-treatment
, 125 126 853 854 O
active 127 133 855 861 O
known 134 139 862 867 O
or 140 142 868 870 O
history 143 150 871 878 O
of 151 153 879 881 O
autoimmune 154 164 882 892 B-chronic_disease
disease 165 172 893 900 I-chronic_disease
that 173 177 901 905 O
might 178 183 906 911 O
recur 184 189 912 917 O
or 190 192 918 920 O
major 193 198 921 926 B-treatment
surgery 199 206 927 934 I-treatment
within 207 213 935 941 O
28 214 216 942 944 B-upper_bound
days 217 221 945 949 I-upper_bound
prior 222 227 950 955 I-upper_bound
to 228 230 956 958 O
the 231 234 959 962 O
first 235 240 963 968 O
dose 241 245 969 973 O
or 246 248 974 976 O
still 249 254 977 982 O
recovering 255 265 983 993 O
from 266 270 994 998 O
prior 271 276 999 1004 B-treatment
surgery 277 284 1005 1012 I-treatment

Subjects 0 8 1013 1021 O
with 9 13 1022 1026 O
peritoneal 14 24 1027 1037 B-cancer
disease 25 32 1038 1045 I-cancer
who 33 36 1046 1049 O
have 37 41 1050 1054 O
failed 42 48 1055 1061 O
prior 49 54 1062 1067 B-treatment
standard 55 63 1068 1076 I-treatment
chemotherapy 64 76 1077 1089 I-treatment
and 77 80 1090 1093 O
have 81 85 1094 1098 O
histologic 86 96 1099 1109 O
confirmation 97 109 1110 1122 O
of 110 112 1123 1125 O
epithelial 113 123 1126 1136 B-cancer
ovarian 124 131 1137 1144 I-cancer
cancer 132 138 1145 1151 I-cancer
or 139 141 1152 1154 O
metastatic 142 152 1155 1165 B-cancer
colorectal 153 163 1166 1176 I-cancer
cancer 164 170 1177 1183 I-cancer
( 171 172 1184 1185 I-cancer
CRC 172 175 1185 1188 I-cancer
) 175 176 1188 1189 I-cancer
including 177 186 1190 1199 O
cancer 187 193 1200 1206 O
originating 194 205 1207 1218 O
from 206 210 1219 1223 O
the 211 214 1224 1227 O
appendix 215 223 1228 1236 O

Treatment 0 9 1237 1246 B-treatment
with 10 14 1247 1251 I-treatment
an 15 17 1252 1254 I-treatment
investigational 18 33 1255 1270 I-treatment
agent 34 39 1271 1276 I-treatment
within 40 46 1277 1283 O
4 47 48 1284 1285 B-upper_bound
weeks 49 54 1286 1291 I-upper_bound
of 55 57 1292 1294 O
starting 58 66 1295 1303 O
study 67 72 1304 1309 O
treatment 73 82 1310 1319 O
or 83 85 1320 1322 O
prior 86 91 1323 1328 O
treatment 92 101 1329 1338 O
with 102 106 1339 1343 O
a 107 108 1344 1345 O
checkpoint 109 119 1346 1356 B-treatment
inhibitor 120 129 1357 1366 I-treatment
( 130 131 1367 1368 O
cytotoxic 131 140 1368 1377 B-treatment
T 141 142 1378 1379 I-treatment
- 142 143 1379 1380 I-treatment
lymphocyte 143 153 1380 1390 I-treatment
- 153 154 1390 1391 I-treatment
associated 154 164 1391 1401 I-treatment
protein 165 172 1402 1409 I-treatment
4 173 174 1410 1411 I-treatment
( 175 176 1412 1413 I-treatment
CTLA-4 176 182 1413 1419 I-treatment
) 182 183 1419 1420 I-treatment
, 183 184 1420 1421 O
programmed 185 195 1422 1432 B-treatment
cell 196 200 1433 1437 I-treatment
death 201 206 1438 1443 I-treatment
protein 207 214 1444 1451 I-treatment
1 215 216 1452 1453 I-treatment
( 217 218 1454 1455 I-treatment
PD-1 218 222 1455 1459 I-treatment
) 222 223 1459 1460 I-treatment
or 224 226 1461 1463 O
programmed 227 237 1464 1474 B-treatment
death 238 243 1475 1480 I-treatment
ligand 244 250 1481 1487 I-treatment
1 251 252 1488 1489 I-treatment
( 253 254 1490 1491 I-treatment
PD 254 256 1491 1493 I-treatment
- 256 257 1493 1494 I-treatment
L1 257 259 1494 1496 I-treatment
) 259 260 1496 1497 I-treatment
antibodies 261 271 1498 1508 I-treatment
) 271 272 1508 1509 O

